COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 1411: Articles 14101-14110  | Next

Ad26.COV2.S elicited neutralizing activity against Delta and other SARS-CoV-2 variants of concern
Jongeneelen, M., Kaszas, K., Veldman, D., Huizingh, J., van der Vlugt, R., Schouten, T., Zuijdgeest, D., Uil, T., van Roey, G., Guimera, N., Navis, M., Bos, R., Le Gars, M., Sadoff, J., Muchene, L., Juraszek, J., Langedijk, J. P., Vogels, R., Custers, J., Schuitemaker, H., Brandenburg, B.
10.1101/2021.07.01.450707 — Posted: 2021-07-01
Correlation between the environmental parameters with outbreak pattern of COVID-19: A district level investigation based on yearlong period in India
Gupta, A., Saha, L.
10.1101/2021.06.28.21259631 — Posted: 2021-07-01
Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection
Zhang, C., Verma, A., Feng, Y., Melo, M. C. R., McQuillan, M., Hansen, M., Lucas, A., Park, J., Ranciaro, A., Thompson, S., Rubel, M. A., Campbell, M. C., Beggs, W., HIRBO, J., Mpoloka, S. W., Mokone, G. G., Regeneron Genetic Center, , Nyambo, T., Meskel, D. W., Belay, G., Fokunang, C., Njamnshi, A. K., Omar, S. A., Williams, S., Rader, D., Ritchie, M. D., de la Fuente Nunez, C., Sirugo, G., Tishkoff, S.
10.1101/2021.06.28.21259529 — Posted: 2021-07-01
A cross-sectional study of the association between frequency of telecommuting and unhealthy dietary habits among Japanese workers during the COVID-19 pandemic
Kubo, Y., Ishimaru, T., Hino, A., Nagata, M., Ikegami, K., Tateishi, S., Tsuji, M., Matsuda, S., Fujino, Y.
10.1101/2021.06.28.21259558 — Posted: 2021-07-01
The Evolution of Young People's Mental Health during COVID-19: Evidence from four Low-and-Middle-Income-Countries
Porter, C., Hittmeyer, A., Favara, M., Scott, D., Sanchez, A.
10.1101/2021.06.28.21259620 — Posted: 2021-07-01
Rotation-based schedules in elementary schools to prevent COVID-19 spread: A simulation study
Brom, C., Diviak, T., Drbohlav, J., Korbel, V., Levinsky, R., Neruda, R., Suchoparova, G., Slerka, J., Smid, M., Trnka, J., Vidnerova, P.
10.1101/2021.06.28.21259628 — Posted: 2021-07-01
Community-Based Phenotypic Study of Safety, Tolerability, Reactogenicity and Immunogenicity of Emergency-Use-Authorized Vaccines Against COVID-19 and Viral Shedding Potential of Post-Vaccination Infections: Protocol for a prospective study
Gabashvili, I. S.
10.1101/2021.06.28.21256779 — Posted: 2021-07-01
Side Effects and Perceptions Following Sinopharm COVID-19 Vaccination
Qubais, B., Al-Shahrabi, R., Alhaj, S. S., Alkokhardi, Z. M., Adrees, A. O.
10.1101/2021.06.28.21258847 — Posted: 2021-07-01
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 infection
Swadling, L., Diniz, M. O., Schmidt, N. M., Amin, O. E., Chandran, A., Shaw, E., Pade, C., Gibbons, J. M., Le Bert, N., Tan, A. T., Tham, C. Y. L., Tan, C., Kucyowicz, S., Aidoo-Micah, G., Rosenheim, J., Davies, J., Jensen, M. P., Joy, G., McCoy, L. E., Valdes, A. M., van Dorp, L., Altmann, D. M., Boyton, R. J., Manisty, C., Treibel, T. A., Moon, J. C., COVIDsortium Investigators, , Balloux, F., McKnight, A., Noursadeghi, M., Bertoletti, A., Maini, M. K.
10.1101/2021.06.26.21259239 — Posted: 2021-07-01
Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda
Frazier, L., Lubinski, B., Tang, T., Daniel, S., Jaimes, J. A., Whittaker, G.
10.1101/2021.06.30.450632 — Posted: 2021-07-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).